CRGY vs CSAN

CRGY presents a conflicted profile with a Piotroski F-Score of 4/9, indicating stable but mediocre financial health. While the stock trades below its Graham Number ($13.82), suggesting defensive value, it trades at a significant premium to its growth-based intrinsic value ($3.78). Severe year-over-year EPS contraction (-103.8%) and a dangerously high dividend payout ratio (88.89%) offset the bullish analyst consensus and low forward P/E. The technical trend is currently bearish (10/100), suggesting a loss of momentum despite strong 1-year gains.

CSAN exhibits severe financial distress as evidenced by a critical Piotroski F-Score of 2/9, indicating weak fundamental health. While the company maintains strong liquidity (Current Ratio 2.58) and impressive operating margins (30.71%), these are completely offset by a negative net profit margin of -24.05% and a catastrophic YoY EPS decline of -712.5%. The stock is in a long-term technical downtrend, losing over 72% of its value over five years, and consistently misses earnings estimates. Despite a low Price/Sales ratio, the negative ROE and poor earnings quality make the current valuation risky.